Month: January 2013

TrisoNIM, first prenatal test noninvasive detecting the Down syndrome, Edwards and Patau. -TrisoNIM ®, innovative test of prenatal testing now available in Spain non-invasive -a simple blood test, without risk for the fetus or the mother. Innovation and technology Spanish. -in Spain occur approximately 470,000 annual births. The age of pregnant women has been increasing and the risks have grown in parallel. Access to the test could prevent 98% of the more than 35,000 amniocentesis performed in Spain each year and that entail risks such as miscarriage of the fetus or the intrauterine infection -a – 5 milliliters of the mother’s blood analysis – just the anguish of the pregnant and can avoid the risks of amniocentesis. The test detects Down, Edwards and Patau syndromes, is done from the first trimester of pregnancy, with results in 3 weeks, with an accuracy of 99.9% to rule out Down syndrome – is the only test currently in marketing in the domestic market, which used massive full genome sequencing. This test has been co-developed by NIMGenetics, the Spanish leader in genetic diagnosis. It’s a technology clinically validated and endorsed by prestigious scientific publications. Allows an early detection of trisomies and facilitates clinical decision Spain, January 2013.- NIMGenetics, Spanish leader in genetic diagnosis with clinical applicability, presents TrisoNIM, prenatal testing test noninvasive, recent launch in Spainwhich allows the early detection of chromosomal abnormalities,...